Inventor · disambiguated record
Matthew D. Shair
Also filed as: LUPIA JOSEPH ANTHONY · SHAIR MATTHEW · SHAIR MATTHEW D
24 granted patents·15 pending applications·98 citations·filing 1994–2025
94Inventor score
Files withHARVARD COLLEGE21NUVALENT INC8SHAIR MATTHEW D3SLOAN KETTERING INST CANCER2JARRELL KEVIN A1
Top patents by PatentIndex Score
39 records- 0194US11542278B1Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2021·Granted Jan 3, 2023·4 cites·30 claims
- 0293US11667649B2Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2021·Granted Jun 6, 2023·3 cites·31 claims
- 0390US9127019B2Cortistatin analogues and synthesis thereofHARVARD COLLEGE·Filed 2014·Granted Sep 8, 2015·7 cites·19 claims
- 0486US12037346B2Amino-substituted heteroaryls for treating cancers with EGFR mutationsNUVALENT INC·Filed 2022·Granted Jul 16, 2024·1 cites·43 claims
- 0578US2024352037A1Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2024·Application pending·0 cites
- 0676US9790253B2OSW-1 analogs and conjugates, and uses thereofSHAIR MATTHEW D·Filed 2012·Granted Oct 17, 2017·3 cites·59 claims
- 0776US7045360B2Method for analysis of reaction productsHARVARD COLLEGE·Filed 2001·Granted May 16, 2006·25 cites·15 claims
- 0875US9714255B2Cortistatin analogues and syntheses thereofHARVARD COLLEGE·Filed 2015·Granted Jul 25, 2017·1 cites·36 claims
- 0975US6495125B2Topical compositions comprising protected functional thiolsPROCTER & GAMBLE·Filed 2001·Granted Dec 17, 2002·4 cites·7 claims
- 1074US12054498B2Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2022·Granted Aug 6, 2024·0 cites·48 claims
- 1174US6797819B1AlkaloidsHARVARD COLLEGE·Filed 2001·Granted Sep 28, 2004·9 cites·22 claims
- 1273US12275742B2Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2022·Granted Apr 15, 2025·0 cites·31 claims
- 1373US9994582B2Cortistatin analogues and syntheses and uses thereofHARVARD COLLEGE·Filed 2016·Granted Jun 12, 2018·1 cites·3 claims
- 1472US2024327435A1Amino-substituted heterocycles for treating cancers with egfr mutationsNUVALENT INC·Filed 2024·Application pending·0 cites
- 1570US6448443B1Synthesis of combinatorial libraries of compounds reminiscent of natural productsHARVARD COLLEGE·Filed 1998·Granted Sep 10, 2002·11 cites·8 claims
- 1669US7109377B2Synthesis of combinatorial libraries of compounds reminiscent of natural productsHARVARD COLLEGE·Filed 2002·Granted Sep 19, 2006·4 cites·6 claims
- 1768US2025382304A1Heteroaromatic macrocyclic ether chemotherapeutic agentsNUVALENT INC·Filed 2025·Application pending·0 cites
- 1864US2011190323A1Cortistatin analogues and syntheses thereofHARVARD COLLEGE·Filed 2009·Application pending·0 cites
- 1963US10508121B2Cortistatin analogues and syntheses and uses thereofHARVARD COLLEGE·Filed 2019·Granted Dec 17, 2019·0 cites·12 claims
- 2062US9321713B2Hyperforin analogs, methods of synthesis, and uses thereofSHAIR MATTHEW D·Filed 2012·Granted Apr 26, 2016·1 cites·33 claims
- 2162US2024374575A1Methods and compositions for treating cancerHARVARD COLLEGE·Filed 2024·Application pending·0 cites
- 2260US5622958AEnediyne quinone imines and methods of preparation and use thereofSLOAN KETTERING INST CANCER·Filed 1994·Granted Apr 22, 1997·24 cites·45 claims
- 2359US10273241B2Cortistatin analogues and syntheses and uses thereofHARVARD COLLEGE·Filed 2018·Granted Apr 30, 2019·0 cites·4 claims
- 2458US10202400B2Cortistatin analogues and syntheses thereofHARVARD COLLEGE·Filed 2017·Granted Feb 12, 2019·0 cites·21 claims
- 2558US2007269858A1Combinatorial BiologyJARRELL KEVIN A·Filed 2007·Application pending·0 cites
- 2651US12509430B2Inhibitors of nicotinamide N-methyltransferase, compositions and uses thereofHARVARD COLLEGE·Filed 2021·Granted Dec 30, 2025·0 cites·19 claims
- 2750US2025340549A1Bicyclic heteroaromatic inhibitors of nicotinamide n-methyltransferase, and compositions and uses thereofHARVARD COLLEGE·Filed 2022·Application pending·0 cites
- 2849US2025368638A1Bicyclic inhibitors of nicotinamide nmethyltransferase, compositions and uses thereofHARVARD COLLEGE·Filed 2022·Application pending·0 cites
- 2947US10273264B2Cortistatin analogues and syntheses and uses thereofHARVARD COLLEGE·Filed 2017·Granted Apr 30, 2019·0 cites·17 claims
- 3046US2018369230A1Targeted selection of patients for treatment with specific cortistatin derivativesHARVARD COLLEGE·Filed 2018·Application pending·0 cites
- 3146US2011319352A1Compounds That Bind Oxysterol Binding Proteins, and Methods of Use ThereofSHAIR MATTHEW D·Filed 2009·Application pending·0 cites
- 3246US2018135134A1Targeted selection of patients for treatment with cortistatin derivativesHARVARD COLLEGE·Filed 2017·Application pending·0 cites
- 3344US2019062340A1Cortistatin analogsHARVARD COLLEGE·Filed 2016·Application pending·0 cites
- 3443US2018298024A1Cortistatin analogs and uses thereofHARVARD COLLEGE·Filed 2018·Application pending·0 cites
- 3541US10273240B2Cortistatin analogues, syntheses, and uses thereofHARVARD COLLEGE·Filed 2017·Granted Apr 30, 2019·0 cites·23 claims
- 3640US2002197653A1System for detecting reporter gene expressionFiled 2002·Application pending·0 cites
- 3737US2001024798A1Biomimetic combinatorial synthesisFiled 2001·Application pending·0 cites
- 3828US6020341AEnediyne quinone imines and methods of preparation and use thereofSLOAN KETTERING INST CANCER·Filed 1995·Granted Feb 1, 2000·0 cites·6 claims
- 3926US9193989B2PRPK-TPRKB modulators and uses thereofPARK EUN SUN·Filed 2011·Granted Nov 24, 2015·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Matthew D. Shair files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →